Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Explore how Roth IRA withdrawals are ordered after conversions, including the treatment of converted amounts and earnings for tax purposes.
18,784 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
When top executives trim their holdings, investors pay attention. This article breaks down what a well timed trim mea...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
A major security misconfiguration at Anthropic left internal assets, including notes on an unreleased model and CEO r...
A federal lawsuit claims Meta’s Ray-Ban AI glasses expose user footage to human reviewers overseas, challenging the c...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...
If you’ve never invested passively, the idea of evaluating a syndicator can feel intimidating. This guide breaks down...
Zcash jumped about 40% in a single session, signaling a renewed push for privacy-focused assets as institutions eye h...
Radian Group's Q1 2026 earnings narrative reveals how the mortgage insurance business is performing, how risk is mana...
A bizarre online listing claims a desk art piece tied to Epstein. This article explores the business case, ethics, an...
A first-look at Vaalco Energy 2026 earnings, what Q1 results might reveal about production, cash flow, and risk. Lear...